Ivax Starts Shipping Generic Paclitaxel; Oral Formulation Paxoral In Phase II

Ivax has started shipping its generic version of Bristol's injectable anti-tumor agent Taxol (paclitaxel), Ivax President Neil Flanzraich told the CIBC World Markets Healthcare Conference in New York City Oct. 25.